We are live on ! Find out more
GNPX icon

Genprex

32 hedge funds and large institutions have $19.5M invested in Genprex in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more call options, than puts

Call options by funds: $1.1M | Put options by funds: $1.08M

0% less ownership

Funds ownership: 0%0% (-0%)

16% less funds holding

Funds holding: 3832 (-6)

32% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 19

45% less capital invested

Capital invested by funds: $35.4M → $19.5M (-$15.9M)

71% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 7

Holders
32
Holders Change
-6
Holders Change %
-15.79%
% of All Funds
0.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
13
Increased
2
Reduced
7
Closed
19
Calls
$1.1M
Puts
$1.08M
Net Calls
+$18K
Net Calls Change
+$516K

GNPX Hedge Fund Activity: Q2 2021 in Review

32 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q2 2021, worth a combined $19.5M — down 45% from $35.4M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of GNPX and 13 opened new positions — a net loss of 6 holders — while 7 trimmed existing stakes and 2 added.

The largest buyer was Millennium Management, adding an estimated $1.31M. The largest seller was BlackRock, cutting an estimated $5.41M.

  • 32 institutional investors held Genprex (GNPX) as of Q2 2021, down from 38 in Q1 2021.
  • Funds reported $19.5M of Genprex stock for Q2 2021, down 45% quarter-over-quarter.
  • 13 funds opened new Genprex positions in Q2 2021 and 19 closed out, a net change of -6 holders.
  • The largest Genprex buyer in Q2 2021 was Millennium Management, an estimated $1.31M added.
  • The largest Genprex seller in Q2 2021 was BlackRock, an estimated $5.41M sold.

Based on aggregated 13F filings for Q2 2021.